Process for the preparation of CCR-2 antagonist

Details for Australian Patent Application No. 2004287810 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Nelson, Dorian; Fleitz, Fred; Cai, Dongwei; Szumigala, Elizabeth; Javadi, Gary; Jensen, Mark; Yang, Lihu; Hoerrner, Scott; Larsen, Robert; Zhou, Changyou; Li, Wenjie; Ge, Min

Agent Spruson & Ferguson

Pub. Number AU-B-2004287810

PCT Pub. Number WO2005/044795

Priority 60/514,754 27.10.03 US

Filing date 25 October 2004

Wipo publication date 19 May 2005

Acceptance publication date 6 January 2011

International Classifications

C07D 207/327 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07C 271/24 (2006.01) Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups

C07C 303/40 (2006.01) Preparation of esters or amides of sulfuric acids

C07D 309/30 (2006.01) Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07C 311/20 (2006.01) Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

Event Publications

18 May 2006 PCT application entered the National Phase

  PCT publication WO2005/044795 Priority application(s): WO2005/044795

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

6 January 2011 Application Accepted

  Published as AU-B-2004287810

12 May 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004287815-Industrial method for separation and purification of fentanyl by reverse phase preparative chromatography

2004287809-Dihydrobenzofuranyl alkanamine derivatives as 5HT2c agonists